Drug Trial Radar · NCT01060696
Efficacy of Mefenamic Acid and Hyoscine for Pain Relief During Saline Infusion Sonohysterography in Infertile Women
Last checked: Nov 20, 2026Latest source record: Feb 2, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
138
Planned (sponsor's estimate)
Start
Jan 2009
Primary completion
Mar 2010
Study completion May 2010
Sponsor
- Lead sponsor
- Mahidol UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Siriraj Hospital
- First posted
- Feb 2, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only, from 20 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The infertility patients who are performed saline infusion sonohysterography (SIS) for studying the pathology inside the uterine cavity has pain. From pilot study the pain score is 6.80. It will have more benefits if we can manage this procedure with less or no pain. Many studies have tried to decrease pain such as types of catheter, intrauterine lidocaine infusion. Some have real effects but no study with oral Mefenamic acid or Hyoscine before the procedure.The drugs are safe and easy to administration and chief.
Conditions
- Infertility
Interventions
Mefenamic acid or Hyoscine or placeboDrug
Mefenamic acid 500 mg. single oral use 30 minutes before SIS Hyoscine 10 mg. single oral use 30 minutes before SIS Placebo single oral use 30 minutes before SIS
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain relief by oral Mefenamic acid or Hyoscine and placebo during saline infusion sonohysterographyTime frame: Before, during and after the procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Siriraj hospital Mahidol university
Bangkok, Bangkok, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.